Repeated administration of (-)sulpiride and SCH 23390 differentially up-regulate D-1 and D-2 dopamine receptor function in rat mesostriatal areas but not in cortical-limbic brain regions.

No abstract is available for this paper.

• Publication year

  1987

• Venue

  European Journal of Pharmacology

• Publication date

  1987-06-12

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1016/0014-2999(87)90335-9PMID 2887436
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Modification of the function of D1 and D2 dopamine receptors in striatum and nucleus accumbens of rats chronically treated with haloperidol.

  1987cited by this paper
• Dopamine Autoreceptors Modulate Dopamine Release from the Prefrontal Cortex

  1986cited by this paper
• 3H-SCH 23390 binding sites in the rat substantia nigra: evidence for a presynaptic localization and innervation by dopamine.

  1986cited by this paper
• D-2 receptor stimulation inhibits cyclic AMP formation brought about by D-1 receptor stimulation in rat neostriatum but not nucleus accumbens.

  1986cited by this paper
• Localisation and pharmacological characterisation of D-2 dopamine receptors in rat cerebral neocortex and cerebellum using [125I]iodosulpride.

  1985cited by this paper
• [3H]SCH 23390 binding sites increase after chronic blockade of D-1 dopamine receptors.

  1985cited by this paper
• Characterization of dopamine receptors mediating inhibition of adenylate cyclase activity in rat striatum.

  1985cited by this paper
• Stimulation of D-2 dopamine receptors in rat mesocortical areas inhibits the release of [3H]dopamine.

  1985cited by this paper
• Evidence for the absence of impulse-regulating somatodendritic and synthesis-modulating nerve terminal autoreceptors on subpopulations of mesocortical dopamine neurons.

  1984cited by this paper
• Bimodal distribution of dopamine receptor densities in brains of schizophrenics.

  1984cited by this paper
• SCH 23390 - the first selective dopamine D-1 antagonist.

  1983cited by this paper
• SCH 23390, a potential benzazepine antipsychotic with unique interactions on dopaminergic systems.

  1983cited by this paper
• Coupling of dopamine D1 recognition sites with adenylate cyclase in nuclei accumbens and caudatus of schizophrenics.

  1983cited by this paper
• Interactions of novel dopaminergic ligands with D-1 and D-2 dopamine receptors.

  1982cited by this paper
• Mesocortical dopamine neurons: rapid transmitter turnover compared to other brain catecholamine systems.

  1981cited by this paper
• Opposing roles for D-1 and D-2 dopamine receptors in efflux of cyclic AMP from rat neostriatum

  1981cited by this paper
• Dopamine and the pathophysiology of dyskinesias induced by antipsychotic drugs.

  1980cited by this paper
• Tardive dyskinesia: review and update.

  1980cited by this paper
• Pharmacologic studies of tardive dyskinesia.

  1980cited by this paper
• Time course of the antipsychotic effect in schizophrenia and some changes in postmortem brain and their relation to neuroleptic medication.

  1980cited by this paper
• Dopamine inhibits adenylate cyclase in human prolactin-secreting pituitary adenomas

  1979cited by this paper
• Multiple receptors for dopamine

  1979cited by this paper
• Regional distribution of monoamines in the cerebral cortex and subcortical structures of the rhesus monkey: concentrations and in vivo synthesis rates.

  1979cited by this paper
• Studies on the pharmacological properties of dopamine receptors in various areas of the central nervous system.

  1978cited by this paper
• Increased dopamine-receptor sensitivity in schizophrenia.

  1978cited by this paper
• Dopaminergic receptors in the anterior pituitary gland. Correlation of [3H]dihydroergocryptine binding with the dopaminergic control of prolactin release.

  1978cited by this paper
• Haloperidol: effect of long-term treatment on rat striatal dopamine synthesis and turnover.

  1977cited by this paper
• Effects of bromocriptine on central dopaminergic receptors.

  1976cited by this paper
• Dopamine receptor binding predicts clinical and pharmacological potencies of antischizophrenic drugs

  1976cited by this paper
• Antipsychotic drug doses and neuroleptic/dopamine receptors

  1976cited by this paper
• Dopamine receptor binding predicts clinical and pharmacological potencies of antischizophrenic drugs.

  1976cited by this paper
• Dopamine metabolism in the mesolimbic and mesocortical dopaminergic systems after single or repeated administrations of neuroleptics.

  1976cited by this paper

• Repeated eticlopride administration increases dopamine D2 receptor expression and restores behavioral flexibility disrupted by methamphetamine exposure to male rats.

  2022cites this paper
• Dopaminergic Modulation of Basal Forebrain Cholinergic Neurons

  2021cites this paper
• Clozapine

  2020cites this paper
• Increased prefrontal cortical D1 receptors in drug naïve patients with schizophrenia: a PET study with [11C]NNC112

  2012cites this paper
• Dopamine D1 and D2 receptor functional regulation: Glutamate Receptor Gene Expression in the Brain of Hypoglycaemic and Hyperglycaemic rats

  2007cites this paper
• The signal attenuation rat model of obsessive–compulsive disorder: a review

  2006cites this paper
• Interactions between D1 and D2 dopamine receptor family agonists and antagonists: the effects of chronic exposure on behavior and receptor binding in rats and their clinical implications

  2005cites this paper
• Dopamine receptor gene expression in streptozotocin induced diabetic rats and its role in insulin secretion

  2003cites this paper
• Selective Alleviation of Compulsive Lever-Pressing in Rats by D1, but not D2, Blockade: Possible Implications for the Involvement of D1 Receptors in Obsessive–Compulsive Disorder

  2003cites this paper
• Prefrontal DA Transmission at D1 Receptors and the Pathology of Schizophrenia

  2003cites this paper
• Differential effects of the dopamine D2/D3 receptor antagonist sulpiride on self-administration of morphine into the ventral tegmental area or the nucleus accumbens

  2002cites this paper
• Role of D1-like receptors in amphetamine-induced behavioral sensitization: a study using D1A receptor knockout mice

  2002cites this paper
• Enhancement of excessive lever-pressing after post-training signal attenuation in rats by repeated administration of the D1 antagonist SCH 23390 or the D2 agonist quinpirole, but not the D1 agonist SKF 38393 or the D2 antagonist haloperidol.

  2001cites this paper
• Modulation of a 40-kDa catecholamine regulated protein by dopamine receptor antagonists.

  2001cites this paper
• Assessment of striatal D1 and D2 dopamine receptor-G protein coupling by agonist-induced [35S]GTP gamma S binding.

  1999cites this paper
• The dopamine hypothesis of schizophrenia: current status, future prospects.

  1997cites this paper
• Regulation of Dopamine Receptor Function and Expression

  1997cites this paper
• Pharmacotoxicological aspects of levosulpiride.

  1995cites this paper
• Subchronic treatment with the neuroleptic-like peptide desenkephalin-gamma-endorphin may decrease dopaminergic neurotransmission in the nucleus accumbens of rats.

  1994cites this paper
• The consequences of long-term antipsychotic drug administration on basal ganglia neuronal function in laboratory animals.

  1994cites this paper
• Chronic antagonist treatment does not alter the mode of interaction of dopamine with rat striatal dopamine receptors.

  1993cites this paper
• Chronic treatment with the D1 receptor antagonist, SCH 23390, and the D2 receptor antagonist, raclopride, in cebus monkeys withdrawn from previous haloperidol treatment

  1993cites this paper
• Receptor subtypes in opioid and stimulant reward.

  1992cites this paper
• D1 receptor stimulation inhibits dopamine cell activity after reserpine treatment but not after chronic SCH 23390: an effect blocked by N-methyl-D-aspartate antagonists.

  1992cites this paper
• Acute administration of amphetamine: differential regulation of dopamine synthesis in dopamine projection fields.

  1992cites this paper
• Efficacy of low vs. high doses of levosulpiride on negative symptoms of schizophrenia.

  1992cites this paper
• Roles of intracellular cAMP and protein kinase A in the actions of dopamine and neurotensin on midbrain dopamine neurons

  1992cites this paper
• Bidirectional potentiation between D1 and D2 dopamine agonists: effects of unilateral intra-accumbens injections on locomotor activity in mice.

  1991cites this paper
• Low doses of l-sulpiride down-regulate striatal and cortical dopamine receptors and beta-adrenoceptors.

  1991cites this paper
• Dopamine receptor 'supersensitivity' occurring without receptor up-regulation.

  1991cites this paper
• Functional recovery of supersensitive dopamine receptors after intrastriatal grafts of fetal substantia nigra.

  1991cites this paper
• Low doses of I-sulpiride down-regulate striatal and cortical dopamine receptors and β-adrenoceptors

  1991cites this paper
• Repeated administration of lisuride down-regulates dopamine D-2 receptor function in mesostriatal and in mesolimbocortical rat brain regions.

  1990cites this paper
• Chronic treatment with SCH 23390 and haloperidol: effects on dopaminergic and serotonergic mechanisms in rat brain.

  1990cites this paper
• Pharmacological and molecular basis for dopamine D-2 receptor diversity

  1990cites this paper
• Dopamine D-1 and D-2 receptors in relation to reward and performance: a case for the D-1 receptor as a primary site of therapeutic action of neuroleptic drugs.

  1990cites this paper
• Resistance to extrapyramidal effects of opiates in rats chronically treated with SCH 23390

  1989cites this paper
• Effects of long-term administration of antidepressants and neuroleptics on receptors in the central nervous system

  1989cites this paper
• Dopamine Receptor Changes During Chronic Drug Administration

  1989cites this paper
• Repeated reserpine administration up-regulates the transduction mechanisms of D1 receptors without changing the density of [3H]SCH 23390 binding.

  1989cites this paper
• Differential effect of acute reserpine administration on D-1 and D-2 dopaminergic receptor density and function in rat striatum.

  1989cites this paper
• Drugs acting on brain dopamine receptors: a conceptual re-evaluation five years after the first selective D-1 antagonist.

  1989cites this paper
• Perinatal bromopride treatment: effects on motor activity and stereotyped behavior of offspring.

  1989cites this paper
• Castration blocks chronic sulpiride-induced desensitization of striatal D1 receptor-stimulated adenylate cyclase activity in male rats.

  1989cites this paper
• Acute extrapyramidal syndrome in Cebus monkeys: development mediated by dopamine D2 but not D1 receptors.

  1989cites this paper
• Status of Dopamine in Bovine Pineal Glands and the Stimulation of N‐Acetyltransferase Activity by D2‐Dopaminergic Receptor Agonists in the Rat Pineal Glands in Culture

  1989cites this paper
• Chapter 1. Antipsychotic Agents

  1988cites this paper
• Acute scopolamine treatment decreases dopamine metabolism in rat hippocampus and frontal cortex.

  1988cites this paper
• Lead neurotoxicity: a role for dopamine receptors.

  1988cites this paper